Head-to-head · Value Score
CoreAge Rx vs Believe Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Believe Health a 41. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameBelieve Health
#417 · Grade C · Watch List
Est. first month
Not disclosed
The verdict
CoreAge Rx takes it on Value Score, 93 to 41 — an est. $99/mo first month, with no teaser step-up baked in. Believe Health isn't out of it: Readers weighing a low-dose protocol who accept that they will complete a long intake, and confirm their answers are accurate, before learning what any of it costs.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Believe Health |
|---|---|---|
| Value Score | 93 (A+) | 41 (C) |
| Est. first month | $99/mo | Not disclosed |
| Save vs brand-name | ~89% | — |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $149/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Believe Health
Three GLP-1 protocols sold entirely without a published price — every treatment page prints "available by consultation" where a figure belongs — on a site that prices nineteen peptide products openly on the page next door.
Why it's a deal
- The compounding disclosure is direct and sits on the treatment pages rather than in a footer: compounded medications are not approved by the FDA and their safety, efficacy and quality have not been independently verified by it
- A dedicated low-dose protocol has its own page and its own framing — metabolic health, body composition and appetite rather than aggressive weight loss — instead of being sold as a cheaper version of a standard plan
- The intake is thorough where it matters clinically: fifteen contraindications are asked about by name, including medullary thyroid carcinoma, family history of it, pancreatitis, type 1 diabetes and active gallbladder disease
- The terms state exactly what a single price is meant to contain — the pharmacy's fee for the drug, the medical group's fee for the provider's services, and the company's own platform fee — even though no figure is attached to it
- A real legal entity, a mailing address and a governing-law clause are published, with a thirty-day arbitration opt-out spelled out
The fine print
- No GLP-1 price is published anywhere. All three treatment pages print "available by consultation" where a figure would sit, and a reader cannot compare this against anything without completing an intake first
- Nineteen peptide products on the same site are priced openly before any intake, which makes the silence on GLP-1s a choice rather than a constraint
- Every treatment page advertises "flat-rate pricing and no hidden fees" and "the price we quote is the price you pay, period" while publishing no rate at all
- Three different cancellation notice periods are published for one product: forty-eight hours in the terms, thirty days in the treatment-page questions, and "cancel anytime" on the checkout copy
- No pharmacy, no medical group and no clinician is named. A census of ten pages and both production files found no name, no identifier and no 503A or 503B designation — and the terms ask a buyer to waive the right to fill the prescription at a pharmacy of their choice, in favor of a party the site never identifies
- The low-dose protocol never says which molecule it contains, on any page
- Coverage is not published: the homepage counter claims fifty states while the treatment-page answer to "where do you operate" reads "across the states where we operate"
- A $35 disposal fee applies to returned prescription medication, on a product the same policy says cannot be returned
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Believe Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.